Anti-Cancer Antibodies May Aid Early Melanoma Detection
Source: Insider Precision Medicine, October 2024
Australian researchers have shown that circulating antibodies against tumor antigens can be used as an accurate biomarker for the early detection of melanoma.
The findings were presented by Cristina Vico-Alonso, MD, lead researcher from the Victorian Melanoma Service, in Melbourne, Australia, at the European Academy of Dermatology and Venereology Congress 2024.
She told Inside Precision Medicine that a test incorporating these antibodies “would provide an earlier and more accurate diagnosis, which is essential for determining the most appropriate subsequent treatment for patients, particularly in the current scenario for melanoma, in which immunotherapy has become a game changer.”